← The Wire
QDELNasdaq
QuidelOrtho Corp
In Vitro & In Vivo Diagnostic Substances · CIK 1906324
QuidelOrtho Corp advances diagnostics for a healthier future through immunoassay, molecular, clinical chemistry, and transfusion medicine testing
red 8-K · 90d
$964M
Market cap
$18.23
Last close
+32.2%
1D
+47.4%
5D
6.6M
Volume
Price · last 39 sessions+46.8%
May 4L $9.96 · H $18.23Jun 29
81
Total filings
Jun 23, 2026
Last filing
01/01
Fiscal year end
8-KExecutive Change · Reg FD DisclosureJun 23, 20268-KShareholder VoteJun 16, 202610-Q10-QMay 6, 20268-KResults of OperationsMay 5, 2026DEFA14ADEFA14AApr 27, 2026DEF 14ADEF 14AApr 27, 20268-KResults of OperationsApr 15, 20268-KExecutive Change · Reg FD DisclosureMar 24, 202610-K10-KFeb 19, 20268-KExecutive ChangeFeb 13, 20268-KResults of OperationsFeb 11, 20268-KExecutive ChangeFeb 5, 20268-KReg FD DisclosureNov 10, 202510-Q10-QNov 6, 20258-KResults of OperationsNov 5, 20258-KMaterial Agreement · New Debt / ObligationAug 21, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 5, 20258-KExecutive Change · Shareholder VoteMay 27, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 7, 2025DEFA14ADEFA14AApr 8, 2025DEF 14ADEF 14AApr 8, 20258-KAuditor ChangeMar 4, 202510-K10-KFeb 27, 20258-KResults of OperationsFeb 12, 20258-KResults of OperationsJan 13, 20258-KExecutive ChangeDec 10, 20248-KExecutive Change · Company UpdateNov 21, 20248-KExecutive ChangeNov 18, 20248-K/AExecutive ChangeNov 18, 2024SC 13GSC 13GNov 13, 20248-KExecutive ChangeNov 8, 202410-Q10-QNov 8, 20248-KResults of OperationsNov 7, 202410-Q10-QAug 1, 202410-K/A10-K/AAug 1, 20248-KResults of OperationsJul 31, 20248-KShareholder VoteMay 17, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 8, 20248-KExecutive Change · Reg FD DisclosureMay 7, 20248-KMaterial AgreementApr 29, 2024DEFA14ADEFA14AApr 2, 2024DEF 14ADEF 14AApr 2, 20248-K/AExecutive ChangeFeb 29, 202410-K10-KFeb 29, 20248-KExecutive ChangeFeb 21, 20248-KReg FD DisclosureFeb 16, 20248-KResults of OperationsFeb 13, 20248-KExecutive ChangeDec 1, 202310-Q10-QNov 2, 20238-KResults of OperationsNov 1, 20238-KResults of OperationsOct 12, 20238-KExecutive ChangeAug 18, 202310-Q10-QAug 9, 20238-KResults of OperationsAug 8, 20238-KShareholder VoteMay 19, 202310-Q10-QMay 4, 20238-KResults of OperationsMay 3, 20238-KResults of OperationsApr 13, 20238-KExecutive ChangeApr 10, 2023DEFA14ADEFA14AApr 5, 2023DEF 14ADEF 14AApr 5, 202310-K10-KFeb 23, 20238-KResults of OperationsFeb 15, 2023SC 13GSC 13GFeb 14, 2023SC 13GSCHEDULE 13GFeb 9, 20238-KResults of OperationsJan 6, 20238-KExecutive Change · Bylaw AmendmentDec 13, 20228-KCompany UpdateDec 5, 202210-Q10-QNov 4, 20228-KResults of OperationsNov 2, 20228-KResults of OperationsOct 12, 20228-KCompany UpdateAug 17, 202210-Q10-QAug 5, 20228-KResults of OperationsAug 4, 20228-KReg FD DisclosureJul 7, 2022SC 13GSC 13GJun 9, 20228-KExecutive ChangeJun 6, 2022
Insider Activity
◆ Cluster Buy · 6 insidersIn the 90 days to Feb 13, 2026: 6 insiders bought $1.3M · 1 sold $112K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 13, 2026 | Blaser Brian J.President and CEO | Buy | 10,540 | $23.59 | $249K |
| Feb 13, 2026 | Strobeck MatthewDirector | Buy | 10,000 | $23.96 | $240K |
| Feb 13, 2026 | Busky Joseph M.Chief Financial Officer | Buy | 3,370 | $23.66 | $80K |
| Feb 13, 2026 | Busky Joseph M.Chief Financial Officer | Buy | 3,370 | $23.66 | $80K |
| Dec 10, 2025 | Rhoads Ann DDirector | Buy | 750 | $28.28 | $21K |
| Nov 26, 2025 | Wilkins Joseph D Jr.Director | Buy | 370 | $27.96 | $10K |
| Nov 25, 2025 | Widder Kenneth JDirector | Sell | 4,026 | $27.81 | $112K |
| Nov 24, 2025 | Busky Joseph M.Chief Financial Officer | Buy | 4,770 | $26.06 | $124K |
| Nov 21, 2025 | Polan Mary Lake Ph DDirector | Buy | 1,000 | $22.43 | $22K |
| Nov 19, 2025 | Blaser Brian J.President and CEO | Buy | 23,500 | $21.34 | $501K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance